Literature DB >> 9353395

M4 muscarinic autoreceptor-mediated inhibition of -3H-acetylcholine release in the rat isolated urinary bladder.

G D'Agostino1, A Barbieri, E Chiossa, M Tonini.   

Abstract

A pharmacological analysis was carried out in the rat urinary bladder to assess the nature of muscarinic receptors subtypes functionally involved in the negative feedback mechanism regulating acetylcholine (ACh) secretion from postganglionic cholinergic nerve terminals and in smooth muscle contraction. Bladder strips were preincubated with 3H-choline, and the electrically evoked [3H]ACh release was detected simultaneously with contraction in the absence of acetylcholinesterase inhibitors. The effects were compared of seven muscarinic antagonists on [3H]ACh secretion (prejunctional effect) and muscle contraction (postjunctional effect). The rank order of postjunctional potencies (-log EC50) for the seven antagonists (atropine > 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) > hexahydrosiladiphenidol hydrochloride (HHSiD) > tripitramine > pirenzepine > AF DX-116 > methoctramine) as well as their postjunctional affinity estimates (pA2) are in keeping with the notion that muscarinic receptors responsible for bladder contraction belong to the M3 subtype. The M3 subtype-preferring 4-DAMP and HHSiD did not discriminate between prejunctional and postjunctional effects. The M2/M4 subtype-preferring antagonists tripitramine, methoctramine and AF-DX 116 were more potent in facilitating the evoked [3H]ACh release than in inhibiting the contractile response. The rank order of prejunctional potencies was atropine > 4-DAMP > tripitramine > HHSiD > methoctramine > AF-DX 116 > pirenzepine, indicating the involvement of M4 receptors. Furthermore, when potency relationship was determined by correlating prejunctional-log EC50 values with published constants for cloned and natives muscarinic receptor subtypes, the correlations were significant for both M4 and M5 subtypes, but the best correlation found (P < .001) was for the M4 subtype. These findings suggest that the negative feedback mechanism inhibiting the release of ACh in the rat urinary bladder is mediated by prejunctional autoreceptors of the M4 subtype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353395

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Integrative control of the lower urinary tract: preclinical perspective.

Authors:  William C de Groat
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 2.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

3.  Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype.

Authors:  G D'Agostino; M L Bolognesi; A Lucchelli; D Vicini; B Balestra; V Spelta; C Melchiorre; M Tonini
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

4.  Characterization of Prejunctional Muscarinic Receptors: Effects on the Release of VIP and Functional Responses and Receptor Expression in the Ovine Submandibular Gland.

Authors:  Anders T Ryberg; Ondrej Soukup; Gunnar Tobin
Journal:  Adv Pharmacol Sci       Date:  2009-05-25

5.  Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice.

Authors:  Yoshihiko Ito; Luvsandorj Oyunzul; Masanao Seki; Tomomi Fujino Oki; Minoru Matsui; Shizuo Yamada
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

6.  The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction.

Authors:  Michel A Pontari; Alan S Braverman; Michael R Ruggieri
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-01-29       Impact factor: 3.619

7.  Free fatty acid receptor 3 activation suppresses neurogenic motility in rat proximal colon.

Authors:  I Kaji; Y Akiba; T Furuyama; D W Adelson; K Iwamoto; M Watanabe; A Kuwahara; J D Kaunitz
Journal:  Neurogastroenterol Motil       Date:  2017-07-17       Impact factor: 3.598

Review 8.  The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.

Authors:  Philippa R Dale; Hana Cernecka; Martina Schmidt; Mark R Dowling; Steven J Charlton; Michael P Pieper; Martin C Michel
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

Review 9.  Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle.

Authors:  Martin C Michel; Sergio Parra
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-12       Impact factor: 3.000

Review 10.  Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment.

Authors:  Ondrej Soukup; Michael Winder; Uday Kumar Killi; Vladimir Wsol; Daniel Jun; Kamil Kuca; Gunnar Tobin
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.